Skip to content

Firm News

Sichenzia Ross Friedman Ference LLP Represents Oasmia Pharmaceutical AB on $9.5M IPO and U.S NASDAQ listing

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Israeli Biotech Company Can-Fite Biopharma on $4.8M Registered Direct Offering of ADSs

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents ContraVir Pharmaceuticals, Inc. on $15 Million Public Offering of Common Stock and Warrants

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Rightscorp in $1.032M PIPE

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents OriginClear, Inc. in $1.5M Acquisition of Progressive Water Treatment, Inc.

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Amarantus BioScience Holdings, Inc. in $5.5M Registered Direct Offering and Private Placement

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Israeli Company Can-Fite BioPharma on $9.0M Public Offering of ADSs

May 6, 2020

Sichenzia Ross Friedman Ference LLP’s Israeli Affiliate DTKGC-SRFF Represents Spectronix in $100M Sale to Emerson Electric

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Aegis Capital as Underwriter on $3.0M Public Offering

May 6, 2020

Sichenzia Ross Friedman Ference LLP Advises Underwriter Aegis Capital on U.S. Initial Public Offering of Israeli Biopharmaceutical Company

May 6, 2020

Sichenzia Ross Friedman Ference LLP Advises DelMar Pharmaceuticals on $2.5M Registered Direct Offering

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Trovagene, Inc. on $40.3M Public Offering of Common Stock

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals Holding Corp. on $20.1M Public Offering

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Cynata on A$5.0M Private Placement

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Israeli-Based Wellsense on $2.0M Private Placement

May 6, 2020

Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp. on $2.1 million Secondary Public Offering of Intellicheck Mobilisa, Inc.

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents LaidLaw & Company (UK) Ltd. on $5.0M Registered Direct Offering of Actinium Pharmaceuticals, Inc

May 6, 2020

Calpian Inc.

May 6, 2020

Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Co. (UK) Ltd. as Sole Book-Running Manager of Viking Therapeutics’ $24.0M IPO

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Ladenburg Thalmann as Placement Agent on Dynatronics’ $4.0M PIPE

May 6, 2020

Sichenzia Ross Friedman Ference LLP Advises Amarantus on $5M PIPE Investment from Discover Growth Fund

May 6, 2020